Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

CALC

CalciMedica Inc

Oct 08 • 04:00PM ET

3.97

Dollar change +0.01
Percentage change 0.25	%

Healthcare • Biotechnology • USA • NASD

Held by: VTI VXF IWC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.88	Insider Own	58.32%	Shs Outstand	5.75M	Perf Week	-6.15%
Market Cap	42.68M	Forward P/E	-	EPS next Y	-1.11	Insider Trans	2.11%	Shs Float	4.48M	Perf Month	-19.88%
Income	-12.59M	PEG	-	EPS next Q	-0.56	Inst Own	18.37%	Short Float	0.55%	Perf Quarter	-13.32%
Sales	0.00M	P/S	-	EPS this Y	79.05%	Inst Trans	-31.34%	Short Ratio	0.66	Perf Half Y	-8.10%
Book/sh	1.29	P/B	3.08	EPS next Y	30.69%	ROA	-60.97%	Short Interest	0.02M	Perf Year	58.48%
Cash/sh	1.78	P/C	2.23	EPS next 5Y	-	ROE	-83.76%	52W Range	1.75 - 8.38	Perf YTD	38.81%
Dividend Est.	-	P/FCF	-	EPS past 5Y	19.56%	ROI	-90.97%	52W High	-52.63%	Beta	1.24
Dividend TTM	-	Quick Ratio	5.22	Sales past 5Y	0.00%	Gross Margin	-	52W Low	126.86%	ATR (14)	0.44
Dividend Ex-Date	-	Current Ratio	5.22	EPS Y/Y TTM	94.74%	Oper. Margin	0.00%	RSI (14)	42.78	Volatility	8.07% 11.68%
Employees	14	Debt/Eq	0.00	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.00	Target Price	16.75
Option/Short	No / Yes	LT Debt/Eq	0.00	EPS Q/Q	68.09%	Payout	-	Rel Volume	0.39	Prev Close	3.96
Sales Surprise	-	EPS Surprise	37.28%	Sales Q/Q	-	Earnings	Aug 12 AMC	Avg Volume	37.69K	Price	3.97
SMA20	-7.44%	SMA50	-9.79%	SMA200	-13.40%	Trades		Volume	14,540	Change	0.25%

Sep-03-24 08:00AM	CalciMedica to Present at the H.C. Wainwright 26th Annual Global Investment Conference (PR Newswire) +7.67%
Aug-12-24 04:10PM	CalciMedica Reports Second Quarter 2024 Financial Results and Provides Clinical & Corporate Updates (PR Newswire)
Jul-09-24 07:30AM	CalciMedica Announces First Patient Enrolled in Phase 2 KOURAGE Trial of Auxora in Severe Acute Kidney Injury (AKI) (PR Newswire)
Jul-08-24 08:00AM	CalciMedica Announces Presentations at Two Upcoming Healthcare Investment Conferences (PR Newswire)
Jul-01-24 08:00AM	CalciMedica Set to Join Russell Microcap Index (PR Newswire) +7.32%
08:00AM	Loading…
Jun-27-24 08:00AM	CalciMedica Announces Positive Topline Data from Phase 2b CARPO Trial of Auxora in Acute Pancreatitis (AP) (PR Newswire) -32.40%
07:06AM	CalciMedica's calcium channel inhibitor helps subgroup of pancreatitis patients eat solids sooner (FierceBiotech.com)
Jun-26-24 04:05PM	CalciMedica to Host Conference Call to Review Topline Data from Phase 2b CARPO Trial of Auxora in Acute Pancreatitis (AP) (PR Newswire) -10.04%
May-28-24 07:53AM	CALC Stock Earnings: CalciMedica Beats EPS for Q1 2024 (InvestorPlace)
May-21-24 09:48AM	3 Massively Undervalued 10-Bagger Stocks to Buy (InvestorPlace)
May-13-24 04:05PM	CalciMedica Reports First Quarter 2024 Financial Results and Provides Clinical & Corporate Updates (PR Newswire) -7.14% +6.73%
May-07-24 08:00AM	CalciMedica Announces Upcoming Presentation at Digestive Disease Week 2024 (PR Newswire)
Apr-24-24 08:00AM	CalciMedica Announces Last Patient Enrolled in Phase 2b CARPO Trial of Auxora in Acute Pancreatitis (PR Newswire) +19.61%
Apr-10-24 03:30PM	Insiders are Piling into These 10 Healthcare Stocks in 2024 (Insider Monkey)
Mar-28-24 11:53AM	CALC Stock Earnings: CalciMedica Reported Results for Q4 2023 (InvestorPlace)
07:00AM	Loading…
07:00AM	CalciMedica Reports 2023 Financial Results and Provides Clinical & Corporate Updates (PR Newswire)
Mar-13-24 08:00AM	CalciMedica Presents Data from Preclinical Studies of Auxora in Acute Kidney Injury at the 29th International AKI & CRRT Conference (PR Newswire)
Feb-28-24 06:57PM	CalciMedica Announces Presentation of Data from a Preclinical Study of Auxora in Acute Kidney Injury at the 29th International AKI & CRRT Conference (PR Newswire)
Feb-13-24 08:00AM	CalciMedica Announces FDA Clearance of IND Application for Phase 2 Trial of Auxora for the Treatment of Severe Acute Kidney Injury (PR Newswire) -8.21%
Feb-07-24 04:05PM	CalciMedica to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference (PR Newswire) +6.92% -9.99%
Jan-22-24 08:00AM	CalciMedica Announces Private Placement of up to Approximately $55 Million (PR Newswire) +7.09%
Dec-11-23 07:30AM	CalciMedica Collaborator St. Jude Children's Research Hospital Presents Data from Initial Cohort of CRSPA Study at 65th Annual ASH Meeting & Exposition (PR Newswire) -13.88%
Nov-09-23 07:00AM	CalciMedica Reports Third Quarter 2023 Financial Results and Provides Clinical & Corporate Updates (PR Newswire) -12.74%
Nov-02-23 09:15AM	CalciMedica Announces Presentation of Initial Data from the CRSPA Study of Auxora at the 65th Annual ASH Meeting & Exposition (PR Newswire) +10.23%
Sep-06-23 07:30AM	CalciMedica Announces Upcoming Presentations and Events in September (PR Newswire) +5.18%
Aug-31-23 07:30AM	CalciMedica to Host Acute Pancreatitis Clinical Experts Event on September 21, 2023 (PR Newswire)
Aug-11-23 07:01AM	Daily Vickers Top Insider Picks for 08/11/2023 (Argus Research)
Aug-10-23 04:05PM	CalciMedica Reports Second Quarter 2023 Financial Results and Provides Clinical & Corporate Updates (GlobeNewswire)
06:24AM	Daily Vickers Top Insider Picks for 08/10/2023 (Argus Research)
Aug-09-23 07:30AM	CalciMedica Announces First Patient Enrolled in International Expansion of CARPO Trial of Auxora in Acute Pancreatitis (AP) (GlobeNewswire) +6.06%
06:26AM	Loading…
06:26AM	Daily Vickers Top Insider Picks for 08/09/2023 (Argus Research)
Aug-08-23 06:28AM	Daily Vickers Top Insider Picks for 08/08/2023 (Argus Research)
Aug-07-23 06:35AM	Daily Vickers Top Insider Picks for 08/07/2023 (Argus Research)
Aug-04-23 07:14AM	Daily Vickers Top Insider Picks for 08/04/2023 (Argus Research)
Aug-03-23 07:15AM	Daily Vickers Top Insider Picks for 08/03/2023 (Argus Research)
Aug-02-23 07:52AM	Daily Vickers Top Insider Picks for 08/02/2023 (Argus Research)
Aug-01-23 06:51AM	Daily Vickers Top Insider Picks for 08/01/2023 (Argus Research) -6.29%
Jul-31-23 06:44AM	Daily Vickers Top Insider Picks for 07/31/2023 (Argus Research)
Jul-28-23 07:58AM	Daily Vickers Top Insider Picks for 07/28/2023 (Argus Research)
Jul-27-23 07:10AM	Daily Vickers Top Insider Picks for 07/27/2023 (Argus Research)
Jul-26-23 01:12PM	Daily Vickers Top Insider Picks for 07/26/2023 (Argus Research)
Jul-25-23 07:16AM	Daily Vickers Top Insider Picks for 07/25/2023 (Argus Research) -6.11%
Jul-24-23 07:12AM	Daily Vickers Top Insider Picks for 07/24/2023 (Argus Research)
Jul-21-23 07:23AM	Daily Vickers Top Insider Picks for 07/21/2023 (Argus Research)
Jul-20-23 06:55AM	Daily Vickers Top Insider Picks for 07/20/2023 (Argus Research)
Jul-19-23 07:10AM	Daily Vickers Top Insider Picks for 07/19/2023 (Argus Research)
Jul-18-23 06:53AM	Daily Vickers Top Insider Picks for 07/18/2023 (Argus Research) -5.56%
Jul-17-23 07:10AM	Daily Vickers Top Insider Picks for 07/17/2023 (Argus Research) +5.16%
Jul-14-23 06:50AM	Daily Vickers Top Insider Picks for 07/14/2023 (Argus Research)
Jul-13-23 07:02AM	Daily Vickers Top Insider Picks for 07/13/2023 (Argus Research)
Jul-12-23 07:22AM	Daily Vickers Top Insider Picks for 07/12/2023 (Argus Research) +7.08%
Jul-11-23 06:08AM	Daily Vickers Top Insider Picks for 07/11/2023 (Argus Research)
Jul-10-23 06:56AM	Daily Vickers Top Insider Picks for 07/10/2023 (Argus Research)
Jul-05-23 06:46AM	Daily Vickers Top Insider Picks for 07/05/2023 (Argus Research) +13.07%
Jul-03-23 06:50AM	Daily Vickers Top Insider Picks for 07/03/2023 (Argus Research)
Jun-30-23 06:52AM	Daily Vickers Top Insider Picks for 06/30/2023 (Argus Research) -17.32%
Jun-29-23 06:49AM	Daily Vickers Top Insider Picks for 06/29/2023 (Argus Research) +11.75%
Jun-28-23 06:58AM	Daily Vickers Top Insider Picks for 06/28/2023 (Argus Research)
Jun-27-23 06:46AM	Daily Vickers Top Insider Picks for 06/27/2023 (Argus Research) +28.00%
Jun-26-23 06:41AM	Daily Vickers Top Insider Picks for 06/26/2023 (Argus Research)
Jun-23-23 09:24AM	Daily Vickers Top Insider Picks for 06/23/2023 (Argus Research) -6.76%
Jun-12-23 07:30AM	CalciMedica Announces Relisting on Nasdaq (GlobeNewswire)
Jun-06-23 07:30AM	CalciMedica Announces Publication of Preclinical Data in Journal of Clinical Investigation (JCI) Insight Supporting the Development of CRAC Channel Inhibitors for Chronic Pancreatitis (CP) (GlobeNewswire) +16.85%
May-23-23 07:30AM	CalciMedica Expands Executive Team with New Appointments (GlobeNewswire) +9.49%
May-15-23 08:55AM	CalciMedica Reports First Quarter 2023 Financial Results and Provides Clinical & Corporate Updates (GlobeNewswire)
Mar-29-23 07:53PM	Charts Point to Higher Highs, Says Oppenheimer. Heres a Stock With Over 100% Upside Potential (TipRanks) -8.76% -29.60%

CalciMedica, Inc. operates as a biopharmaceutical company. It focuses on developing therapies for life-threatening inflammatory diseases. The firm's product candidate Auxora helps in treating acute pancreatitis and asparaginase-associated pancreatitis. The company was founded by Kenneth A. Stauderman and Gonul Velicelebi in 2007 and is headquartered in La Jolla, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Dunn Michael J.	President and COO	Sep 09 '24	Option Exercise	1.39	11,761	16,348	11,761	Sep 11 05:00 PM
Leheny A. Rachel	CHIEF EXECUTIVE OFFICER	Aug 27 '24	Buy	4.19	1,000	4,190	110,926	Aug 27 07:44 PM
Roberts Eric W	CHIEF BUSINESS OFFICER	Aug 23 '24	Buy	3.57	5,000	17,867	46,894	Aug 26 06:00 PM
WILSON ROBERT N	Director	Aug 23 '24	Buy	3.72	54,000	200,826	364,196	Aug 26 05:57 PM
Roberts Eric W	CHIEF BUSINESS OFFICER	Aug 21 '24	Buy	4.04	5,000	20,200	44,894	Aug 22 06:02 PM
WILSON ROBERT N	Director	Jun 28 '24	Buy	3.52	51,278	180,499	310,196	Jul 02 04:50 PM
WILSON ROBERT N	Director	Jun 27 '24	Buy	3.23	8,443	27,305	258,918	Jul 01 03:12 PM
Roberts Eric W	CHIEF BUSINESS OFFICER	Jun 27 '24	Buy	3.22	5,000	16,100	10,223	Jun 28 06:52 PM
Roberts Eric W	CHIEF BUSINESS OFFICER	Apr 02 '24	Buy	3.90	3,254	12,691	39,894	Apr 02 08:33 PM
Roberts Eric W	CHIEF BUSINESS OFFICER	Apr 01 '24	Buy	3.90	746	2,909	36,640	Apr 02 08:33 PM
MIDDLETON FRED A	Director	Jan 23 '24	Buy	3.70	679,384	2,515,080	946,744	Jan 25 08:00 PM
Sanderling Venture Partners VI	10% Owner	Jan 23 '24	Buy	3.70	436,028	1,614,176	727,433	Jan 25 08:00 PM
Sanderling Venture Partners VI	10% Owner	Jan 23 '24	Buy	3.70	243,356	900,904	946,744	Jan 25 08:00 PM
WILSON ROBERT N	Director	Dec 11 '23	Buy	3.30	506	1,670	182,161	Dec 13 08:45 PM
Leheny A. Rachel	Chief Executive Officer	Nov 07 '23	Buy	3.34	2,000	6,680	18,840	Nov 08 08:42 PM
Roberts Eric W	Chief Business Officer	Nov 06 '23	Buy	3.12	2,400	7,488	35,894	Nov 08 08:41 PM
Roberts Eric W	Chief Business Officer	Nov 03 '23	Buy	2.83	11,249	31,846	33,494	Nov 07 08:42 PM
Roberts Eric W	Chief Business Officer	Nov 03 '23	Buy	2.77	3,700	10,249	20,287	Nov 07 08:42 PM
Leheny A. Rachel	Chief Executive Officer	Nov 06 '23	Buy	3.12	2,440	7,615	16,840	Nov 07 06:09 PM
Hebbar Sudarshan	Chief Medical Officer	Nov 03 '23	Buy	2.74	36,000	98,600	46,000	Nov 07 06:08 PM
Roberts Eric W	Chief Business Officer	Nov 03 '23	Buy	2.70	5,860	15,828	22,245	Nov 06 06:40 PM
Roberts Eric W	Chief Business Officer	Nov 03 '23	Buy	2.80	3,200	8,960	16,587	Nov 06 06:40 PM
Leheny A. Rachel	Chief Executive Officer	Nov 03 '23	Buy	2.85	5,000	14,250	14,400	Nov 06 06:39 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CALC

CalciMedica Inc

Upgrade your FINVIZ experience